Internal Medicine, Infectious Disease · Boston, MA
NPI
1396060133
Since 2010
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
800 Washington St
Boston, MA, 02111
Phone (617) 636-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
800 services
Medicare patients, 2024
238
Average age 72
Drug cost, 2024
$2.0M
1,419 prescriptions
Company payments, 2023
$27.42
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary J Hopkins was code 99233 (hospital e&m - subsequent), 211 times for 70 patients. In total Mary J Hopkins billed 800 services in 22 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 211 | 70 | $98.03 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 144 | 71 | $12.94 | $1,863 |
| 99223 Hospital E&M - Initial | Facility | 94 | 91 | $141.74 | $13K |
| 99214 Office E&M - Established | Facility | 89 | 53 | $75.09 | $6,683 |
| 99215 Office E&M - Established | Facility | 75 | 44 | $110.11 | $8,259 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 44 | 25 | $24.88 | $1,095 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 18 | $65.13 | $1,758 |
| 99214 Office E&M - Established | Office | 23 | 13 | $98.71 | $2,270 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 12 | $13.74 | $302 |
By year: 2022 $60K for 595 services; 2023 $50K for 486 services; 2024 $63K for 800 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary J Hopkins prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 168 prescriptions and refills. In total Mary J Hopkins wrote 1,419 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 168 | 168 | 26 | $677K |
| Tivicay Dolutegravir Sodium | 74 | 74 | 11 | $169K |
| Atorvastatin Calcium Generic | 57 | 155 | 17 | $748 |
| Lisinopril Generic | 57 | 138 | 16 | $430 |
| Descovy Emtricitabine/Tenofov Alafenam | 54 | 54 | Under 11 | $123K |
| Pifeltro Doravirine | 37 | 41 | Under 11 | $72K |
| Prezcobix Darunavir/Cobicistat | 29 | 29 | Under 11 | $67K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 26 | 58 | Under 11 | $938 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 26 | 27 | Under 11 | $611 |
| Ozempic Semaglutide | 26 | 35 | Under 11 | $29K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 24 | 62 | Under 11 | $469 |
| Cabenuva Cabotegravir/Rilpivirine | 24 | 42 | Under 11 | $150K |
| Zolpidem Tartrate Generic | 22 | 22 | Under 11 | $59.87 |
| Ondansetron Hcl Generic | 21 | 21 | Under 11 | $258 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 21 | 21 | Under 11 | $72K |
Brand drugs: - claims; generic drugs: 793 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Mary J Hopkins $27.42 ($27.42 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $27.42.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $27.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.